Co-operation between patient organisations and the drug industry in Finland

Hemminki, Elina; Toiviainen, Hanna; Vuorenkoski, Lauri

doi:10.1016/j.socscimed.2010.01.005

Cited by 37 publications

(59 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Like certain influential scholars working on pharmaceutical policy (Hemminki et al 2010(Hemminki et al , p. 1172, we employed a deductive-inductive approach to coding. To examine the expectations formulated based on the theories of the state, we started with a set of general codes informed by the research questions, supplementing them by "in-vivo" codes emerging directly from the data (Charmaz 2006, pp.…”

Section: Methodsmentioning

confidence: 99%

Governing drug reimbursement policy in Poland: The role of the state, civil society, and the private sector

Ozierański

King

2017

Theor Soc

View full text Add to dashboard Cite

This article investigates the distribution of power in Poland's drug reimbursement policy in the early 2000s. We examine competing theoretical expectations suggested by neopluralism, historical institutionalism, corporate domination, and clique theory of the post-communist state, using data from a purposive sample of 109 semistructured interviews and documentary sources. We have four concrete findings. First, we uncovered rapid growth in budgetary spending on expensive drugs for narrow groups of patients. Second, to achieve these favorable policy outcomes drug companies employed two prevalent methods of lobbying: informal persuasion of key members of local cliques and endorsements expressed by patient organizations acting as seemingly independent "third parties." Third, medical experts were co-opted by multinational drug companies because they relied on these firms for scientific and financial resources that were crucial for their professional success. Finally, there was one-way social mobility from the state to the pharmaceutical sector, not the "revolving door" pattern familiar from advanced capitalist countries, with deleterious consequences for state capacity. Overall, the data best supported a combination of corporate domination and clique theory: drug reimbursement in Poland was dominated by Western multinationals in collaboration with domestically based cliques.

show abstract

Section: Methodsmentioning

confidence: 99%

Governing drug reimbursement policy in Poland: The role of the state, civil society, and the private sector

Ozierański

King

2017

Theor Soc

View full text Add to dashboard Cite

show abstract

“…The most frequently reported on outcome was the proportion of organizations that receive industry funding (65%). Six studies were questionnaire surveys . The median proportion of organizations that receive industry funding in five studies was 62% (IQR: 34%‐69%).…”

Section: Resultsmentioning

confidence: 99%

Financial relationships between patient and consumer representatives and the health industry: A systematic review

Khabsa

Semaan

El‐Harakeh

et al. 2019

Health Expectations

View full text Add to dashboard Cite

Background Patients and consumers are increasingly engaged in health policymaking, research and drug regulation. Having financial relationships with the health industry creates situations of conflicts of interest (COI) and might compromise their meaningful and unbiased participation. Objective To synthesize available evidence on the financial relationships between the health industry and patient and consumer representatives and their organizations. Methods We systematically searched MEDLINE and EMBASE. We selected studies and abstracted data in duplicate and independently. We reported on outcomes related to financial relationships of individuals with, and/or funding of organizations by the health industry. Results We identified a total of 14 510 unique citations, of which 24 reports of 23 studies were eligible. Three studies (13%) addressed the financial relationship of patient and consumer representatives with the health industry. Of these, two examined the proportion of public speakers in drug regulatory processes who have financial relationships; the proportions in the two studies were 25% and 19% respectively. Twenty studies (87%) addressed funding of patient and consumer organizations. The median proportion of organizations that reported funding from the health industry was 62% (IQR: 34%‐69%) in questionnaire surveys, and 75% (IQR: 58%‐85%) in surveys of their websites. Among organizations for which there was evidence of industry funding, a median proportion of 29% (IQR: 27%‐44%) acknowledged on their websites receiving that funding. Conclusion Financial relationships between the health industry and patient and consumer representatives and their organizations are common and may not be disclosed. Stricter regulation on disclosure and management is needed.

show abstract

“…Parallèlement, mais de manière corrélée, se pose la question des interactions et des enjeux qui unissent certaines organisations de patients et de consommateurs à l'industrie pharmaceutique. De nombreux travaux ont déjà décrit les rapports qu'entretiennent ces deux types d'acteurs [12][13][14][15]. En 2004, l'association HyperSupers fut lauréate du prix de Proximologie décerné chaque année par le laboratoire pharmaceutique qui commercialise la Ritaline.…”

Section: Un Système D'interrelations à Décrireunclassified

Le trouble déficitaire de l’attention avec hyperactivité

Jupille

2011

Med Sci (Paris)

View full text Add to dashboard Cite

Co-operation between patient organisations and the drug industry in Finland

Cited by 37 publications

References 11 publications

Governing drug reimbursement policy in Poland: The role of the state, civil society, and the private sector

Governing drug reimbursement policy in Poland: The role of the state, civil society, and the private sector

Financial relationships between patient and consumer representatives and the health industry: A systematic review

Le trouble déficitaire de l’attention avec hyperactivité

Contact Info

Product

Resources

About